RBC Stock UPDATES Regal-Beloit Corp (RBC) 69.60 10/30/2014 0

New Post Public Reply Private Reply Replies (0) Message Board

Oct 30, 2014 at 4:22 AM

Regal-Beloit Corp (RBC) 69.60 $RBC

Regal Beloit Corporation To Present At Baird's 2014 Industrial Conference
PR Newswire - Wed Oct 29, 5:12PM CDT
Regal Beloit Corporation (NYSE:RBC) will be presenting at Baird's 2014 Industrial Conference on November 11, 2014 at 2:30pm CST.
RBC: 69.60 (-0.27)

Regal Beloit Corporation To Hold Third Quarter 2014 Earnings Conference Call On Tuesday, November 4, 2014
PR Newswire - Mon Oct 06, 4:29PM CDT
Regal Beloit Corporation (NYSE: RBC) announced today that it plans to release its third quarter 2014 financial results after the market closes on Monday, November 3, 2014.
RBC: 69.60 (-0.27)

Downgrade Alert for Regal-Beloit (RBC)
Comtex SmarTrend(R) - Tue Sep 23, 7:01AM CDT
Regal-Beloit (NYSE:RBC) was downgraded from Buy to Accumulate at Global Hunter today. The stock closed yesterday at $65.82 on volume of 440,000 shares, above average daily volume of 241,000. There is potential upside of 26.7% for shares of Regal-Beloit based on a current price of $65.84 and an average consensus analyst price target of $83.41. The stock should find initial resistance at its 50-day moving average (MA) of $71.82 and further resistance at its 200-day MA of $73.96.
RBC: 69.60 (-0.27)

Regal Beloit Corporation Announces Scheduling Change At Morgan Stanley Second Annual Laguna Conference
PR Newswire - Tue Sep 16, 11:18AM CDT
Regal Beloit Corporation (NYSE:RBC) today announced a change in the presentation schedule at the Morgan Stanley Second Annual Laguna Conference on September 16, 2014. Regal Beloit Corporation will now be presenting at 1:35pm PDT (4:35pm EDT).
RBC: 69.60 (-0.27), MS: 34.39 (+0.03)

Health Care REIT Boosts Liquidity; Guides 2H14 Buyouts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 9:50AM CDT
Health Care REIT (HCN) disclosed the common shares offering to strengthen its liquidity position and its projected acquisition pipeline for the second half of 2014.
GS: 186.08 (-0.24), HCN: 69.21 (-0.49), OHI: 38.83 (-0.63), RBC: 69.60 (-0.27)

Regal Beloit Corporation To Present At The Morgan Stanley Second Annual Laguna Conference
PR Newswire - Wed Sep 03, 4:33PM CDT
Regal Beloit Corporation (NYSE:RBC) will be presenting at the Morgan Stanley Second Annual Laguna Conference on September 16, 2014 at 4:30pm PDT.
RBC: 69.60 (-0.27), MS: 34.39 (+0.03)

Insider Trading Alert - APA, RBC And ACHC Traded By Insiders
at The Street - Fri Aug 22, 11:15AM CDT
Stocks with insider trader activity include APA, RBC and ACHC
ACHC: 52.91 (-0.22), RBC: 69.60 (-0.27), APA: 76.39 (+1.15)

Regal Beloit Corporation To Present At The Jefferies 2014 Global Industrials Conference
PR Newswire - Thu Aug 07, 4:48PM CDT
Regal Beloit Corporation (NYSE:RBC) will be presenting at the Jefferies 2014 Global Industrials Conference August 13, 2014 at 2:00pm EDT.
RBC: 69.60 (-0.27)

NYSE stocks posting largest percentage decreases
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
PWT.TO: 5.17 (+0.07), CRR: 52.25 (-0.14), AXR: 3.85 (-0.05), OCN: 20.81 (+1.18), BZH: 17.95 (-0.18), AVG: 17.17 (-0.18), GNW: 13.65 (+0.02), MTW: 19.88 (-0.33), PWE: 4.62 (+0.07), RBC: 69.60 (-0.27), ASGN: 29.91 (+0.46), CHMT: 22.36 (-1.12), LLL: 117.49 (+0.73), SB: 5.54 (-0.12)

NYSE stocks posting largest volume increases
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
PWT.TO: 5.17 (+0.07), IPHI: 15.20 (+0.74), ESC: 33.46 (-0.13), GNW: 13.65 (+0.02), LEN: 43.42 (-0.50), PWE: 4.62 (+0.07), JRN: 9.58 (+0.12), CUZ: 12.85 (-0.06), RBC: 69.60 (-0.27), SSP: 18.78 (+0.22), ASGN: 29.91 (+0.46), LEN.B: 35.40 (-0.29), TMUS: 28.59 (-0.26), CBS.A: 54.40 (+0.31), CBS: 54.06 (-0.01)

Regal Beloit Meets Q2 Earnings Estimates, Revenues up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 11:10AM CDT
Regal Beloit (RBC) reported second-quarter 2014 adjusted earnings of $1.27 per share, up 12.4% from $1.13 in the year-ago quarter. Earnings were in line with the Zacks Consensus Estimate.
CW: 69.63 (-0.28), RBC: 69.60 (-0.27), EMR: 63.30 (-0.08), POWL: 43.87 (-0.11)

/C O R R E C T I O N -- Regal Beloit Corporation/
PR Newswire - Tue Jul 29, 7:21PM CDT
In the news release, Regal Beloit Corporation Announces Second Quarter 2014 Financial Results, issued 29-Jul-2014 by Regal Beloit Corporation over PR Newswire, we are advised by the company that the Adjusted Income from Operations table in the Non-GAAP Measures section has changes to the Adjusted Income from Operations line items for both the three and six month periods ended June 28, 2014, as originally issued inadvertently. This correction ONLY impacted the Adjusted Income from Operations table. All other amounts in the original earnings release were correct. The complete, corrected release follows:
RBC: 69.60 (-0.27)

Regal Beloit Corporation Announces Second Quarter 2014 Financial Results
PR Newswire - Tue Jul 29, 4:37PM CDT
Regal Beloit Corporation (NYSE: RBC) today reported financial results for the second quarter 2014. Net sales for the second quarter 2014 were $850.4 million compared to $822.0 million for the second quarter 2013. Net income for the second quarter 2014 was $56.2 million compared to $51.1 million for the second quarter 2013. Diluted earnings per share for the second quarter 2014 were $1.24 compared to $1.13 for the second quarter 2013. Adjusted diluted earnings per share were $1.27 for the second quarter 2014 compared to $1.13 for the second quarter 2013.
RBC: 69.60 (-0.27)

Regal Beloit announces USD0.22 per share dividend for quarter
M2 - Mon Jul 28, 3:00AM CDT
Chairman and chief executive officer Mark J Gliebe of Regal Beloit Corporation (NYSE:RBC), a manufacturer of electric motors, mechanical and electrical motion controls and power generation products, disclosed on Friday that its board of directors authorised a regular quarterly dividend of USD0.22 per share.
RBC: 69.60 (-0.27)

Regal Beloit Declares Dividend
PR Newswire - Fri Jul 25, 5:31PM CDT
Mark J. Gliebe, Chairman and Chief Executive Officer of Regal Beloit Corporation (NYSE: RBC), announced that the Board of Directors, at its regular quarterly meeting held on July 25, 2014, declared a dividend of $.22 per share. The dividend is payable on October 8, 2014, to shareholders of record at the close of business on September 24, 2014. This represents the 217th consecutive dividend declared by the Company.
RBC: 69.60 (-0.27)

Macquarie to Fund IMTT Buy With New Debt, Share Issuance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 11, 11:50AM CDT
Macquarie Infrastructure (MIC) announced the pricing of an underwritten public offering of 10 million shares and also of $305 million worth of five-year convertible senior notes, to fund the buyout of International-Matex Tank Terminals.
BCS: 14.31 (-0.28), MIC: 66.50 (-0.19), JPM: 59.29 (-0.34), RBC: 69.60 (-0.27)

New Technologies, Appointments, New Contracts, and Conference Call Schedules - Analyst Notes on ExOne, Nordson, B&W, Regal and Hillenbrand
PR Newswire - Thu Jul 03, 5:30AM CDT
Today, Analysts Review released its analysts' notes regarding The ExOne Company (NASDAQ: XONE), Nordson Corporation (NASDAQ: NDSN), The Babcock & Wilcox Company (NYSE: BWC), Regal Beloit Corporation (NYSE: RBC) and Hillenbrand, Inc. (NYSE: HI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4396-100free.
NDSN: 75.23 (-0.14), BWC: 28.33 (-0.16), HI: 32.87 (-1.12), RBC: 69.60 (-0.27), XONE: 24.08 (-0.50)

Regal Beloit Acquires Benshaw - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 9:40AM CDT
Regal Beloit Corporation (RBC) recently acquired Benshaw Inc. from Curtiss-Wright Corporation (CW) for $50 million.
CW: 69.63 (-0.28), FELE: 37.11 (-1.99), RBC: 69.60 (-0.27), ESE: 36.82 (-0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...